Reuters: Regulatory News: CORRECTED-BRIEF-Transcept Pharma, Purdue Pharma file action against Novel

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

CORRECTED-BRIEF-Transcept Pharma, Purdue Pharma file action against Novel Sep 11th 2012, 21:19 Tue Sep 11, 2012 5:19pm EDT (Corrects headline to say Transcept and Purdue filed action alleging patent infringement by Novel Labs. They received a Paragraph IV notice letter from Novel on July 31, which was reported earlier) Sept 11 (Reuters) - Sept 11 (Reuters) - Transcept Pharmaceuticals Inc : * Transcept pharmaceuticals Inc joined Purdue Pharmaceutical products, Purdue Pharma L.P. in filing action against Novel - SEC filing * Action alleging infringement of the '628 patent' and seeking injunctive and other relief against Novel. * Commencement of the action automatically stays FDA approval of the Novel ANDA until January 2015 (Reporting by Balaji Sridharan in Bangalore)

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions